Screening for markers of frailty and perceived risk of adverse outcomes using the Risk Instrument for Screening in the Community (RISC) by O'Caoimh, Rónán et al.
O’Caoimh et al. BMC Geriatrics 2014, 14:104
http://www.biomedcentral.com/1471-2318/14/104RESEARCH ARTICLE Open AccessScreening for markers of frailty and perceived risk
of adverse outcomes using the Risk Instrument
for Screening in the Community (RISC)
Rónán O’Caoimh1,7*, Yang Gao1, Anton Svendrovski2, Elizabeth Healy3, Elizabeth O’Connell4, Gabrielle O’Keeffe5,
Una Cronin1, Eileen O’Herlihy1, Nicola Cornally1,6 and William D Molloy1,7Abstract
Background: Functional decline and frailty are common in community dwelling older adults, increasing the risk of
adverse outcomes. Given this, we investigated the prevalence of frailty-associated risk factors and their distribution
according to the severity of perceived risk in a cohort of community dwelling older adults, using the Risk Instrument
for Screening in the Community (RISC).
Methods: A cohort of 803 community dwelling older adults were scored for frailty by their public health nurse (PHN)
using the Clinical Frailty Scale (CFS) and for risk of three adverse outcomes: i) institutionalisation, ii) hospitalisation and
iii) death, within the next year, from one (lowest) to five (highest) using the RISC. Prior to scoring, PHNs stated whether
they regarded patients as frail.
Results: The median age of patients was 80 years (interquartile range 10), of whom 64% were female and 47.4%
were living alone. The median Abbreviated Mental Test Score (AMTS) was 10 (0) and Barthel Index was 18/20 (6). PHNs
regarded 42% of patients as frail, while the CFS categorized 54% (scoring ≥5) as frail. Dividing patients into low-risk
(score one or two), medium-risk (score three) and high-risk (score four or five) using the RISC showed that 4.3%
were considered high risk of institutionalization, 14.5% for hospitalization, and 2.7% for death, within one year of
the assessment. There were significant differences in median CFS (4/9 versus 6/9 versus 6/9, p < 0.001), Barthel
Index (18/20 versus 11/20 versus 14/20, p < 0.001) and mean AMTS scores (9.51 versus 7.57 versus 7.00, p < 0.001)
between those considered low, medium and high risk of institutionalisation respectively. Differences were also
statistically significant for hospitalisation and death. Age, gender and living alone were inconsistently associated
with perceived risk. Frailty most closely correlated with functional impairment, r = −0.80, p < 0.001.
Conclusion: The majority of patients in this community sample were perceived to be low risk for adverse
outcomes. Frailty, cognitive impairment and functional status were markers of perceived risk. Age, gender and
social isolation were not and may not be useful indicators when triaging community dwellers. The RISC now
requires validation against adverse outcomes.
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Functional decline and frailty are common in community
dwelling older adults [1-3] and influence the risk of
adverse outcomes. Identifying those likely to develop
adverse outcomes is important in order to target limited
healthcare resources in an efficient and effective manner.
Risk assessment utilizing different risk prediction models
is increasingly being used in the community [4]. Risk
describes the amount of potential harm that can occur
in a set period of time due to a specific event, or series
of events and is the product of the probability that
harm will occur and the magnitude of its severity [5-7].
Rational decision-making in healthcare requires reliable
and valid quantitative ways of expressing risk that balance
the potential costs and benefits of different management
strategies [8].
Multiple factors including cognitive impairment, depres-
sion, medical comorbidities, low levels of physical activity
and social isolation are associated with an increased
risk of adverse outcomes [9-11]. Many but not all of
these predispose to the development of frailty [12]. These
factors can be grouped into three main categories or
domains: mental state, activities of daily living (ADLs)
and medical state. The ability of each individual’s care-
giver network and social supports to manage the person’s
care deficit also affects their level of risk. Inadequate social
or caregiver networks predict mortality and contribute
to other poor healthcare outcomes [13,14], including
institutionalization [15,16].
A variety of different methods have been used in an
attempt to identify community dwellers at risk of adverse
outcomes. Many focus on the identification of frailty [17],
acting as short surrogates for Comprehensive Geriatric
Assessment [18]. They include direct (home assessment)
[19] and indirect (postal survey) [20-22], targeted and
non-targeted assessment strategies [23]. Indirect and non-
targeted community screening is less efficient, suggesting
that rapid screening, followed by triage and appropriate
management of high-risk individuals is most effective [23].
Although the stratification of risk scores using these
instruments is associated with clinically meaningful
gradients of adverse outcomes [4], most risk prediction
models have poor predictive ability [4]. This is especially
true at an individual level and may relate to a failure to
incorporate important personalized social and demo-
graphic data [4].
Community healthcare nurses known also as public
health nurses (PHNs), visit patients in their home and
may be in the best position to screen older people, both
opportunistically and proactively. PHNs play a key role in
all areas of healthcare delivery in the community, includ-
ing assessment of care needs [24] and can be trained to
deliver specific interventions from psychosocial strategies
[25] to interventions for chronic medical conditions [26]in the home environment. In some countries, people with
chronic illnesses such as dementia are more likely to be
attended by PHNs than other healthcare professionals
[27]. Studies have found high levels of frailty related risk
factors among patients under PHN follow-up in the com-
munity [28]. Despite this, few studies have examined the
role of PHNs in the care of frail and functionally impaired
community dwelling older adults. In particular, few studies
consider the factors that influence PHNs’ decision-making
or that contribute to their interpretation of risk.
The purpose of this study was first to establish the
prevalence of risk factors for frailty and functional decline
in a sample of community dwelling older adults moni-
tored by PHNs in Ireland, second to identify factors
associated with perceived risk of adverse outcomes and
third to investigate their distribution according to the
severity of that perceived risk using a new risk stratifi-
cation model, the Risk Instrument for Screening in the
Community (RISC).
Methods
Patients
A random sample of older adults, under regular follow-
up, in two PHN sectors in Cork City and County in
Southern Ireland were selected by convenience sampling.
Community dwellers, including those living in supervised
(sheltered) accommodation, aged over 65 years and
followed-up by a PHN were included. Subjects were ex-
cluded if they were in institutional care (nursing home or
other long-term care unit) or under 65 years.
Data collection and sampling
This paper reports initial findings of the Community As-
sessment of Risk and treatment Strategies (CARTS) study,
an ongoing prospective cohort study of community dwell-
ing older adults followed by PHNs in Southern Ireland as
part of Irelands European Innovation Partnership on Active
and Healthy Ageing reference site COLLAGE (COLLabor-
ation on AGEing) [29,30]. PHN sectors covering urban,
suburban and some rural areas in southern Ireland, were
approached and invited to participate. Ballincollig and
Bishopstown, and Mahon and Ballintemple public health
centres in County Cork were the first respondents and
were sampled in that order. Sampling was thus based on
the non-probability method of convenience sampling using
a quota method. All PHNs (n = 15) from these centres were
asked to participate and include all patients under their
care who were under regular follow-up. Prior to assessing
their cases, PHN’s were trained and certified in scoring the
RISC (previously called the Community Assessment of Risk
Screening Tool) [31]. All subjects were then scored by
PHNs using this instrument. Scoring was based on the
PHNs knowledge of the patients and each PHN only
scored subjects directly under their care. Prior to scoring,
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frail or not, yes or no, the PHNs’ own assessment of frailty.
Additional patient information was abstracted for the PHN
nursing records by a clinician, blinded to the RISC scores.
This included (where available) age, gender, education,
medications, medical comorbidities, indication for referral,
source of referral (professional and self-referral), use of
home supports and objective measures of cognition and
ADL function. Ethical approval was granted by the Clinical
Research Ethics Committee of the Cork Teaching Hospi-
tals in advance of the study. Although consent was not
required for retrospective chart review, informed written
consent was obtained from all patients included in the
CARTS intervention study. Assent was obtained from rel-
atives of those unable to provide consent.
Outcome measures
Perceived risk of three adverse outcomes namely, institu-
tionalisation, hospitalisation and death, occurring in the
next year, were scored using the RISC. Institutionalisation
was defined as admission to a nursing home or other
long-term care institution. Hospitalisation was defined
as an acute, non-elective admission to hospital. The RISC
is a new, reliable screening and assessment instrument
designed to measure one-year risk of three adverse out-
comes: institutionalisation, hospitalisation and death
[31]. The instrument collects demographic data and
records the presence and magnitude (mild, moderate,
severe) of concern across three domains: mental state,
ADLs and medical state. Based upon the caregiver net-
works’ ability to manage each domain, an overall global
risk score is then attributed to each adverse outcome.
The global risk score is scored using a five-point Likert
scale, ranking risk from one (minimal and rare) to five
(extreme and certain). The RISC consists of Yes or No
responses to the presence of a concern for the three
domains. Developed in conjunction with PHNs, through
an iterative process, the RISC takes 2–5 minutes to
complete and is currently being validated in different
samples of community dwelling older adults. The RISC
score sheet is presented in Figure 1.
Standardized testing, including the Barthel Index (BI)
[32] and Abbreviated Mental Test Score (AMTS) [33],
were conducted routinely by PHNs. The BI is a 20-point
measure of basic ADL’s where a score of 20 indicates
independence and 0 denotes complete functional depend-
ence. The AMTS is a ten-point score of cognition where
ten suggests normal cognition and zero severe cognitive
impairment. A cut-off of seven (<7) is considered suggest-
ive of cognitive impairment. In addition, the PHN scored
each patient on the Clinical Frailty Scale (CFS) [34], a
validated measure of frailty. This is a nine-point scale,
scored from one (very fit) to nine (terminally ill) and
can be corrected for people with dementia. Medicationuse and medical issues were also identified. Co-morbidity
data were extracted from the PHN nursing records. The
overall burden of co-morbidity was measured using the
Charlson Co-morbidity Index [35].
Statistical analysis
Data were entered into SPSS version 18.0. Kolmogorov-
Smirnov and Shapiro-Wilk tests were used to test for
normality. Normally distributed data were compared using
Students t-tests. Non-normally distributed data were
compared with the Mann–Whitney U test. Correlations
were determined using Pearson’s or Spearman’s rho
(non-parametric data). Kruskal-Wallis and Pearsons Chi
Squared tests (categorical outcomes) were used to com-
pare distributions.
Results
Demographics
The baseline demographic data is summarized in Table 1.
In total 803 patients were reviewed. The most common
indication for PHN involvement was review post dis-
charge from hospital (n = 329, 41%) followed by assess-
ment for services, including provision of aids and
appliances (n = 265, 33%), wound care (n = 88, 11%) and
other (n = 121, 15%). The mean age of patients, across the
two sectors, was 79.8 years, with a standard deviation
(SD) of +/−7.4, median age of 80 years and interquartile
range (IQR) of 10. There were 516 females, (64%) and 287
males, (36%). The mean age of females was 80.2 years
(+/−7.4) compared to 79 (+/−7.5) for males. Females were
significantly older, (p = 0.04). Educational level was avail-
able for 415 subjects. Of these, 154 (31%) had primary
education, 178 (43%) secondary and 83 (20%), third level.
Overall, 374 (47.4%) subjects were living alone, most of
whom were female, (n = 268, 71.7%). The sample was
predominantly urban/suburban (n = 746, 93%) and the
majority (n = 724, 90%) lived in their own residences.
The prevalence of co-morbidities found in the study popu-
lation is presented in Table 2. The median Charleston
Co-morbidity Index score was one (two) and scores
ranged from 0–10. The mean number of total prescription
medications prescribed per person was 5.5 (+/−3.4),
median of five (5), range 0–18.
Cognition
The mean AMTS was 9.26 (+/−1.7) with a median of 10
(0). In all, 134 patients were regarded as having cognitive
impairment, a cohort prevalence of 16.7%. The mean age
of those with cognitive impairment was 81.8 years (+/−7),
significantly older than those with normal cognition
(mean 79.4, SD +/−7.5, p = 0.001). Subjects with cognitive
impairment were more likely to be female, 70% versus
62.9% (p < 0.001) and more functionally impaired than
those without documented cognitive impairment (median
Figure 1 Risk Instrument for Screening in the Community (RISC) score sheet.
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Table 1 Baseline demographic data including a comparison between those scoring minimum (score 1 and 2/5) and maximum (score 3, 4 and 5/5) risk on the
Risk Instrument for Screening in the Community (RISC)
Descriptor Total
(Percentage)
RISC institutionalization P-value RISC hospitalization P-value RISC death P-value
Minimum risk Maximum risk Minimum risk Maximum risk Maximum risk Maximum risk
N = 686 N = 96 N = 499 N = 283 N = 621 N = 161
Age (Mean ± SD) 79.8 ± 7.4 79.7 ± 7.4 81.8 ± 6.7 < 0.01 80 ± 7.3 79.9 ± 7.4 0.99 79 ± 7 83.2 ± 7.7 < 0.001
Gender F 516 (64%) 65% 67% 0.70 69% 57% 0.001 67% 59% 0.08
M 287 (36%) 35% 33% 31% 43% 33% 41%
Educational Level (where available) 0.02 0.06 < 0.01
- Primary 154 (37%) 35% 48% 33% 42% 33% 50%
- Secondary 178 (43%) 46% 27% 48% 36% 47% 30%
- Third 83 (20%) 19% 25% 19% 22% 20% 20%
Living alone Y 381 (47%) 48% 41% 0.18 52% 40% < 0.01 49% 43% 0.20
N 422 (53%) 52% 59% 48% 60% 51% 57%
Accommodation type 0.22
- Own home 724 (90%) 93% 85% < 0.01 93% 89% 0.02 93% 89%
- Sheltered accommodation 21 (3%) 1% 0% 0% 2% 1% 1%
- Another’s home 58 (7%) 6% 15% 6% 9% 6% 10%
Home Help Y 419 (52%) 50% 81% < 0.001 48% 63% < 0.001 53% 57% 0.29
(Any type) N 384 (48%) 50% 19% 52% 37% 47% 43%
Home help hours < .001
0 384 (48%) 58% 21% < 0.001 60% 42% < 0.001 55% 49%
≤5 335 (41%) 34% 44% 34% 39% 37% 31%
6-10 40 (5%) 4% 14% 4% 8% 5% 7%
11-20 24 (3%) 2% 10% 2% 5% 3% 6%
>20 20 (3%) 2% 11% 1% 6% 1% 7%
Abbreviated Mental Test Score (Mean ± SD) 9.25 ± 1.86 9.51 ± 1.46 7.38 ± 3.07 < 0.001 9.43 ± 1.60 8.94 ± 2.23 < 0.001 9.41 ± 1.58 8.64 ± 2.61 < 0.001
Cognitive Impairment Y 134 (16.7%) 21% 75% < 0.001 22% 41% < 0.001 24% 47% < 0.001
N 669 (83.3%) 79% 25% 78% 59% 76% 53%
Barthel Index Score (Median ± IQR) 18 ± 6, range 0-20 18 ± 4, 0-20 12 ± 6, 0-20 < 0.001 19 ± 4, 0-20 16 ± 7, 0-20 < 0.001 18 ± 4, 0-20 15 ± 9, 0-20 < 0.001
PHNs own opinion of frailty Y 335 (42%) 37% 76% < 0.001 71% 63% < 0.001 36% 65% < 0.001
N 468 (58%) 63% 24% 29% 37% 64% 35%
Clinical Frailty Scale Score (Median ± IQR) 5 ± 2, range 0-9 4 ± 3, 0-9 6 ± 1, 2-8 < 0.001 4 ± 2, 0-8 6 ± 2, 2-9 < 0.001 4 ± 3, 0-8 6 ± 2, 2-9 < 0.001
Clinical Frailty Score ≥5 422 (54%) 49% 91% < 0.001 44% 73% < 0.001 49% 75% < 0.001
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Table 1 Baseline demographic data including a comparison between those scoring minimum (score 1 and 2/5) and maximum (score 3, 4 and 5/5) risk on the
Risk Instrument for Screening in the Community (RISC) (Continued)
Charlson Comorbidity Index (Median ± IQR) 1 ± 2, range 0-10 1 ± 2, 0-9 2 ± 2, 0-10 < 0.001 1 ± 1, 0-7 2 ± 2, 0-10 < 0.001 1 ± 2, 0-8 2 ± 2, 0-10 < 0.001
Total number medications (Median ± IQR) 5 ± 5, range 0-18 5 ± 4.3, 0-18 7 ± 5, 1-16 0.001 4 ± 5, 0-14 7 ± 5, 0-18 < 0.001 5 ± 4, 0-16 6 ± 5, 0-18 < 0.001
Admissions in last year (Median ± IQR) 1 ± 1, range 0-10 1 ± 1, 0-10 1 ± 0, 1-5 0.17 1 ± 1, 0-6 1 ± 1, 1-10 > 0.05 1 ± 1, 0-10 1 ± 1, 1-6 0.19
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Table 2 Prevalence of documented co-morbidities
abstracted from nursing records for patients under care
of their Public Health Nurse (n = 803)
Condition Prevalence %
(n = 803)
Hypertension 311 (39%)
Osteoarthritis 285 (36%)
Ischaemic heart disease 150 (19%)
Dementia 134 (16.7%)
Cancer (any history including skin) 127 (16%)
Anxiety-depression 119 (15%)
Atrial Fibrillation (any history) 98 (12%)
Diabetes mellitus (type 1 or 2) 91 (11%)
Stroke (infarction) 79 (10%)
Hypothyroidism 62 (8%)
Chronic obstructive pulmonary disease 59 (7%)
Venous hypertension 49 (6%)
Peripheral vascular disease 43 (5%)
Alcohol excess 40 (5%)
Parkinson’s disease 32 (4%)
Chronic kidney disease 27 (3%)
Psychosis (including schizophrenia,
bipolar affective disorder)
25 (3%)
Congestive cardiac failure 23 (3%)
Seizure disorder 23 (3%)
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ment were as likely to be living alone as those without
documented cognitive impairment, p = 0.11. There was a
strong significant correlation between the AMTS and a
documented diagnosis of cognitive impairment (r = 0.77,
p < 0.001). There was a medium significant correlation be-
tween the BI and both cognitive impairment (r = −0.4, p <
0.001) and AMTS scores (r = 0.35, p < 0.001).
Function and frailty
The median BI score for the total population was 18 (6).
There was no statistically significant difference in BI
scores between males and females, both had a median
score of 18, z = −1.22, p = 0.23. There was no correlation
between age and functional ability, r = −0.150, p < 0.001
using the BI score. The PHNs own opinion of frailty,
without use of a standardized frailty instrument, described
335 (42%) subjects as frail. Of these, 130 (39%) were living
alone. The CFS was available for 784 patients (97%), 426
(54.3%) of whom scored >5 and were categorized as
mildly frail-terminally ill. A further 171 (21.8%) scored 4,
vulnerable, while 187 (23.9%) scored three or less, very
fit-managing well. The distribution of CFS scores is pre-
sented in Figure 2. The correlation between the CFS and
the variables collected is presented in Table 3. Therewas a strong, significant correlation between the PHNs
own opinion of frailty and the CFS, r = 0.56, p < 0.001,
and between the BI and the CFS, r = −0.80, p < 0.001.
There was small to medium, correlation between the
Charleston Co-Morbidity Index and the CFS (r = 0.29,
p < 0.001) and small or no correlation between the CFS
and age (r = 0.12, p = 0.001), and gender (r = 0.05, p = 0.2).
The CFS also correlated moderately and significantly
with the RISC scores, r = 0.43 (institutionalization), r = 0.43
(hospitalization) and r = 0.35 (death), p < 0.001 (see Table 3).
Comparing the PHNs own assessment of frailty to the CFS
classification of frailty (score of four or less is non-frail)
showed that the nurses opinion had a sensitivity of 65%
and specificity of 85.7% for frailty with a positive predictive
value of 84.3% and negative predicative value of 67.5%.
Risk scores
Of those reviewed, RISC scores were available for 782
patients. After pooling the risk levels into low-risk (a
score of one or two), medium-risk (score of three) and
high-risk (score of four or five) using the RISC, 4.3% of
the total sample were perceived by their PHN to be at
high risk of institutionalisation, 14.5% at high risk of
hospitalisation, and 2.7% at high risk of death, within
one year of the assessment. The presence of documented
cognitive impairment increased the perceived risk of
institutionalisation for the high-risk group to 15%. Over-
all, the majority of patients were regarded as low risk for
each of the adverse outcomes. This is illustrated in
Figure 3a. There was a significant difference in median
CFS (4/9 ± 3 versus 6/9 ± 1 versus 6/9 ± 0, p < 0.001),
Barthel Index (18/20 ± 4 versus 11/20 ± 7 versus 14/20 ±
7, p < 0.001) and mean AMTS scores (9.51 ± 1.46 versus
7.57 ± 3.11 versus 7.00 ± 2.99, p < 0.001) between patients
considered low, medium and high risk of institutionali-
sation respectively. Differences were also statistically
significant for hospitalisation and death.
Further dividing patients into minimum (score of one or
two, n = 686) or maximum-risk (scoring three, four or five
on the RISC, n = 96) increased the percentage considered
at risk to 12.3%, 36.2% and 20.6% for institutionalisation,
hospitalisation and death respectively within one year of
the assessment. Patients considered to be at maximum-
risk of insitutionalisation were more likely to be frail as
judged by the CFS (49% versus 91%, p < 0.001), function-
ally impaired (BI of 18/20 versus 12/20,p < 0.001) and
cognitively impaired (21% versus 75%, p < 0.001). This
association was similar for those considered at maximum
risk of hospitalisation and death, see Table 1. Gender and
living alone were not associated with perceived risk of
institutionalisation or death. Age was not associated with
perceived risk of hospitalisation. Most variables were
significantly different for all three adverse outcomes
including the prevalence of cognitive impairment (AMTS
Figure 2 Distribution of clinical frailty scale scores in the study population (n = 784).
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PHNs own opinion of frailty scores) and comorbidities
(Charlson Comorbidity Index scores), see Table 1. The
prevalence of RISC outcomes, using a score of three or
higher as the cut-off for maximum risk, according to the
CFS, is presented in Figure 3b. Patients CFS scores were
divided into very fit-managing well (score 1–3), vulnerable
(score of 4) and mildly frail-terminally ill (score 5–9),
n = 784. Perceived risk of hospitalisation was greater than
institutionalisation and death for all three CFS frailty
levels with 48.3% of mildly frail-terminally ill patients
perceived to be at maximum risk of hospitalisation
within one year, significantly different from very fit-Table 3 Correlation of patient variables to the level of
frailty as measured by the Clinical Frailty Scale
Variable Correlation to clinical
frailty scale (p value)
Age 0.12 (p = 0.001)
Gender 0.05 (p = 0.2)
Living alone 0.21 (p < 0.001)
Nurses “own” opinion of frailty 0.56 (p < 0.001)
Barthel Index −0.80 (p < 0.001)
Cognitive impairment (documented) 0.38 (p < 0.001)
Abbreviated mental test score 0.36 (p < 0.001)
Charlson comorbidity index 0.29 (p < 0.001)
Total number of medications 0.25 (p < 0.001)
No of hospital admissions in the last year 0.19 (P < 0.001)
Receiving home help (any type) 0.32 (p < 0.001)
RISC score:
- global risk institutionalisation 0.43 (p < 0.001)
- global risk hospitalisation 0.43 (p < 0.001)
- global risk death 0.35 (p < 0.001)managing well (17.7%) and vulnerable (25.1%) patients,
(χ2(2) = 62.37,p < 0.001). Perceived risk was also signifi-
cantly different according to the frailty level for institutio-
nalisation (χ2(2) = 58.17,p < 0.001) and death (χ2(2) = 36.65,
p < 0.001).
Discussion
This paper presents the prevalence of several established
predictors of functional decline and frailty among com-
munity dwelling older adults being monitored by their
PHN. It also presents the type and prevalence of factors
that contribute to PHNs’ perceived risk of adverse out-
comes, scored using a new screening and assessment
instrument, the RISC. There was a high prevalence (54%)
of frailty, as defined by CFS scores of 5 to 9 (mildly frail-
terminally ill) [34], among this cohort of community
dwellers. This was expected, given that patients being
followed by PHNs are a selected sample of older adults and
are more likely to have medical and other co-morbidities
than a cross sectional sample of all community dwelling
older adults.
Several variables correlated strongly with frailty. These
included function as determined by the BI and notably
PHNs own “opinion” of frailty. The close correlation of
the CFS to the BI likely reflects the scoring mechanism
of the CFS, which depends on the functional stage of
the patient. That the opinion of PHNs in this sample
correlated strongly and significantly with a validated
measure of frailty, the CFS [34], suggests that health-
care workers, familiar with their patients, accurately
predict risk without the need for standardized assess-
ment instruments. Several established factors such as
age [36] and female gender [37], that might increase
the likelihood of frailty, were not found to correlate
with the CFS. Of the other risks identified, CI in particular,
correlated with the degree of functional impairment
a.
b.
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Figure 3 The prevalence of perceived one-year risk of adverse outcomes of institutionalisation, hospitalisation and death, for available
patients assessed using the a) Risk Instrument for Screening in the Community (RISC) and b) the prevalence of RISC outcomes according to
the Clinical Frailty Scale (CFS), n = 784.
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However, several challenges remain in separating frailty
as a concept from the individual factors that are associated
with it. It is not established whether these factors, includ-
ing markers of cognition and functional impairment, cause
or merely reflect the development of frailty. Future studies
should include established objective markers, such as those
included in the Fried criteria [38] like weight, grip strength
and walking speed, which may help clarify the interaction
between the components of frailty and the frailty pheno-
type as a whole.
In this sample, only a small percentage of the total
older adult population was perceived to be living at risk.
Perceived risk of adverse outcomes, within one year of
assessment was generally low. This corresponds with low
prevalence rates of institutionalisation and death from the
community. Previous analysis of a risk register of commu-
nity dwelling older adults in County Cork, Ireland, found
a similar prevalence of perceived risk [39]. In that sample
the composite risk of all adverse outcomes was measuredat 7%. In this study, cognition, functional level and frailty
correlated with the perceived risk of institutionalisation,
although gender and social isolation did not. In particular,
cognitive impairment increased the perceived risk of all
adverse outcomes, suggesting that these patients should
receive particular attention when they live in the commu-
nity. Pooling results, into low, medium and high or indeed
into minimum and maximum increased the number of
patients perceived to be at increased risk. Perceived risks
were significantly greater for those rated as frail on the
CFS compared with those rated as non-frail or frail.
Perceived risk of hospitalisation was higher than for the
other adverse outcomes. Most patients however, even
in this highly selected community sample, were regarded
as being low risk of adverse events.
This paper has several limitations. The data collection
was based upon a retrospective review of the patients’
PHN records and the analysis depended upon these be-
ing accurate and up to date. Some demographic data in-
cluding 21 RISC and 19 CFS scores were not available
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six months. Sampling PHN records may also have led to
selection bias in that patients followed by their PHN are
inherently at higher risk of adverse outcomes compared
to the general older adult population. The method of
sampling may also have created bias. However, with
quota sampling investigators are less concerned with
having sufficient numbers to match the proportions in
the entire population, but instead aim to sample enough
patients to ensure that even small subgroups are ad-
equately represented. Additionally, it is not certain that
all PHNs correctly classified patients according to their
risk. The study was however, conducted in conjunction
with each patient’s PHN, who know their patients well
and provide care for them over several years. Another
limitation is that since the RISC is still being validated,
the ability to generalize and prognosticate on the signifi-
cance of the risk factors associated with the perceived
risk identified are reduced. Once validated, further ana-
lysis will be required to investigate the association of
these markers of frailty and perceived risk with the out-
come data. Likewise, the optimal cut-off point for each
adverse outcome is not yet established. The CFS has also
not been validated with nurses, which may have lead to
bias. Although we assessed the inter-rater reliability of
the RISC, the reliability of the CFS was not determined.
The subjectivity of the frailty assessment is another limi-
tation. Both the PHNs own assessment of frailty and the
CFS are subjective measures, and the inclusion of an
objective observer rated assessment instrument would
have reduced potential bias. Furthermore, the screening
tools used for cognition and function in this study are
not gold standard instruments and may have under-
estimated the true prevalence of cognitive and functional
impairment in this population. The AMTS is less accurate
than many other short cognitive screens such the Quick
mild cognitive impairment screen [40] and the Montreal
Cognitive Assessment [41] and is particularly insensi-
tive at differentiating mild cognitive impairment from
normal cognition and early dementia. Likewise, the BI
is a crude gauge of function and does not score instru-
mental ADLs. These instruments are however, widely used
and are the prescribed instruments in use in the commu-
nity in this region. The Charleston Co-morbidity Index is
criticized for its poor predictive validity, particularly among
older adults [42]. In particular, it fails to incorporate
medical conditions like Parkinson’s disease, multiple scler-
osis and inflammatory bowel disorders, which may con-
tribute to comorbidity.
The strengths of this paper are the comprehensive nature
of the review of the PHN records, conducted in busy
health centres and the inclusion of a large cross-sectional
and representative community sample, increasing the gene-
ralizability of the results. The prevalence of comorbiditiesreported in this study are similar to other community
samples of other PHNs in Ireland [28]. A retrospective
cross sectional clinical audit carried out in Dublin City,
Ireland, investigating the prevalence of four frailty-related
risk factors identified similar rates of suspected cognitive
(16.4%) and functional impairment (BI score ≤15, 23.5%)
albeit they were slightly higher in this study at 16.7% and
30.6% respectively [28].
The RISC was developed to measure risk patients'
levels and is in the process of being validated. It was de-
signed with PHNs for use in a community setting and
shows excellent inter-rater reliability (IRR) [31]. This re-
search is ongoing, and a follow-up is underway to ascer-
tain the current status of the patients and evaluate the
predictive validity of the RISC to these adverse outcomes
in this population. This prospective cohort study will in-
vestigate if risk scores, described by the RISC, predict
these adverse outcomes. Targeting limited resources, to
medium and high-risk individuals (maximum risk),
could improve efficiency in the use of limited health-
care resources [43]. Future studies will investigate if the
RISC, aligned to tailored intervention programmes or
care bundles, can reduce risk and incidence of adverse
outcomes in community dwelling older adults.Conclusions
In this study the majority of community dwelling older
adults were perceived by their PHN to be at minimum
risk of adverse outcomes. This may facilitate targeting of
these patients to prevent or postpone adverse outcomes.
On the other hand, there was a large proportion of frail
older adults (54%; ≥5 on the CFS) found in this study,
and it remains to be seen if simple, albeit multidimen-
sional, risk scores like the RISC may be more efficient in
targeting patients for Comprehensive Geriatric Assess-
ment than instruments like the CFS. Frailty (subjective
or objective), cognitive impairment and functional status
were markers of perceived risk. PHNs opinion appears
to correlate with a validated frailty scale, supporting the
utility of nurses in triaging patients in the community.
Several factors traditionally associated with frailty such
as age, gender and social isolation did not correlate with
the CFS, RISC or with PHNs’ perceived risk of adverse
outcomes, suggesting that despite their high prevalence,
they may not be useful indicators for triaging community
dwellers.
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